The UK’s largest listed companies are turning their heads towards the glimmer of the Nasdaq after growing impatient ...

Parnassus Investments, an investment management firm, released its “Parnassus Value Equity Fund” second-quarter 2025 investor ...

Pharmaceutical stocks are some of the biggest in the FTSE 100. The sector is threatened by tariffs, but some have posted encouraging results regardless.

SINGAPORE] Asia-Pacific could be the new frontier for biotechnology investment, a report by consulting firm Bain & Company ...

AstraZeneca (($AZN)) has held its Q2 earnings call. Read on for the main highlights of the call. AstraZeneca’s recent earnings call showcased a ...

AstraZeneca's CEO said the company has proposed U.S. price cuts to some drugs, while Doximity enters competitive AI scribing ...

Dan Lefkovitz of Morningstar I recently interviewed investor and author Daniel Rasmussen for The Long View podcast, where he ...

The consolidation is expected to continue as long as the frontline indices trade below the 50-day EMA. Below are some ...

Tempus AI offers a strong business model with AI-driven genomic data, resilient demand, and significant growth prospects.

The biggest fallers on the FTSE 100 were Taylor Wimpey, down 6.7p at 100.45p, ConvaTec, down 13.40p at 231.0p, HSBC, down ...

Havas has announced a joint venture between HAVAS Red and H/Advisors in Singapore. This will provide customers with a world ...

The FTSE 100 index closed up just 0.62 of a point at 9,136.94. The FTSE 250 closed 16.49 points lower, 0.1%, at 21,776.58, and the AIM All-Share closed down 3.03 points, 0.4%, at 762.72.